Henner Koch

Henner Koch

Auto-generated profile, based on publicly available information

Henner Koch

Department of Neurology, Department of Epileptology, RWTH Uniklinik, RWTH Aachen, Aachen, Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2019 in eLife
Verified
Journal Article
Open access
NSNiklas Schwarz
Niklas Schwarz
BUBetül Uysal
Betül Uysal
MWMarc Welzer
Marc Welzer
JBJacqueline C Bahr
Jacqueline C Bahr
NLNikolas Layer
Nikolas Layer
HKHenner Koch
Henner Koch
Most of our knowledge on human CNS circuitry and related disorders originates from model organisms. How well such data translate to the human CNS remains largely to be determined. Human brain slice cultures derived from neurosurgical resections may offer novel avenues to approach this translational gap. We now demonstrate robust preservation of the complex neuronal cytoarchitecture and electrophysiological properties of human pyramidal neurons in long-term brain slice cultures. Further experiments delineate the optimal conditions for efficient viral transduction of cultures, enabling ‘high throughput’ fluorescence-mediated 3D reconstruction of genetically targeted neurons at comparable quality to state-of-the-art biocytin fillings, and demonstrate feasibility of long term live cell imaging of human cells in vitro. This model system has implications toward a broad spectrum of translational studies, regarding the validation of data obtained in non-human model systems, for therapeutic screening and genetic dissection of human CNS circuitry.

25 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NSNiklas Schwarz
Niklas Schwarz
UHUlrike B. S. Hedrich
Ulrike B. S. Hedrich
HSHannah Schwarz
Hannah Schwarz
HPHarshad P.A.
Harshad P.A.
NDNele Dammeier
Nele Dammeier
HKHenner Koch
Henner Koch
Pathophysiological investigation of CNS-related diseases, such as epilepsy or neurodegenerative disorders, largely relies on histological studies on human post mortem tissue, tissue obtained by biopsy or resective surgery and on studies using disease models including animal models, heterologous expression systems or cell culture based approaches. However, in general it remains elusive to what extent results obtained in model systems can be directly translated to the human brain, calling for strategies allowing validation or even primary investigation in live human CNS tissue. In the work reported here, we prepared human organotypic slice cultures from access tissue of resective epilepsy surgery. Employing different culture conditions, we systematically compared artificial culturing media versus human cerbrospinal fluid (hCSF) obtained from patients with normal pressure hydrocephalus (NPH). Presented data demonstrates sustained cortical neuronal survival including not only maintenance of typical cellular electrophysiological properties and activity, such as robust action potential generation and synaptic connectivity, but also preservation of tonic and phasic network activity up to several weeksin vitro. As clearly delineated by immunocytochemistry, single cell patch clamp and extracellular recordings, we find that in contrast to artificial culturing media, hCSF significantly enhances neuron viability and maintenance of network activity.

4 January 2024 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
LTLewis W. Taylor
Lewis W. Taylor
ESElizabeth M. Simzer
Elizabeth M. Simzer
CPClaire Pimblett
Claire Pimblett
OLOscar T. T. Lacey-Solymar
Oscar T. T. Lacey-Solymar
RMRobert I. McGeachan
Robert I. McGeachan
CDClaire S. Durrant
Claire S. Durrant
Tau hyperphosphorylation and aggregation is a common feature of many dementia-causing neurodegenerative diseases. Tau can be phosphorylated at up to 85 different sites, and there is increasing interest in whether tau phosphorylation at specific epitopes, by specific kinases, plays an important role in disease progression. The AMP-activated protein kinase (AMPK)-related enzyme NUAK1 has been identified as a potential mediator of tau pathology, whereby NUAK1-mediated phosphorylation of tau at Ser356 prevents the degradation of tau by the proteasome, further exacerbating tau hyperphosphorylation and accumulation. This study provides a detailed characterisation of the association of p-tau Ser356 with progression of Alzheimer’s disease pathology, identifying a Braak stage-dependent increase in p-tau Ser356 protein levels and an almost ubiquitous presence in neurofibrillary tangles. We also demonstrate, using sub-diffraction-limit resolution array tomography imaging, that p-tau Ser356 co-localises with synapses in AD postmortem brain tissue, increasing evidence that this form of tau may play important roles in AD progression. To assess the potential impacts of pharmacological NUAK inhibition in an ex vivo system that retains multiple cell types and brain-relevant neuronal architecture, we treated postnatal mouse organotypic brain slice cultures from wildtype or APP/PS1 littermates with the commercially available NUAK1/2 inhibitor WZ4003. Whilst there were no genotype-specific effects, we found that WZ4003 results in a culture-phase-dependent loss of total tau and p-tau Ser356, which corresponds with a reduction in neuronal and synaptic proteins. By contrast, application of WZ4003 to live human brain slice cultures results in a specific lowering of p-tau Ser356, alongside increased neuronal tubulin protein. This work identifies differential responses of postnatal mouse organotypic brain slice cultures and adult human brain slice cultures to NUAK1 inhibition that will be important to consider in future work developing tau-targeting therapeutics for human disease.

11 August 2021 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
MBMelanie Barth
Melanie Barth
MBMehtap Bacioglu
Mehtap Bacioglu
NSNiklas Schwarz
Niklas Schwarz
RNRenata Novotny
Renata Novotny
JBJanine Brandes
Janine Brandes
GTGaye Tanriöver
Gaye Tanriöver
Background: Proteopathic brain lesions are a hallmark of many age-related neurodegenerative diseases including synucleinopathies and develop at least a decade before the onset of clinical symptoms. Thus, understanding of the initiation and propagation of such lesions is key for developing therapeutics to delay or halt disease progression. Methods: Alpha-synuclein (αS) inclusions were induced in long-term murine and human slice cultures by seeded aggregation. An αS seed-recognizing human antibody was tested for blocking seeding and/or spreading of the αS lesions. Release of neurofilament light chain (NfL) into the culture medium was assessed. Results: To study initial stages of α-synucleinopathies, we induced αS inclusions in murine hippocampal slice cultures by seeded aggregation. Induction of αS inclusions in neurons was apparent as early as 1week post-seeding, followed by the occurrence of microglial inclusions in vicinity of the neuronal lesions at 2–3 weeks. The amount of αS inclusions was dependent on the type of αS seed and on the culture’s genetic background (wildtype vs A53T-αS genotype). Formation of αS inclusions could be monitored by neurofilament light chain protein release into the culture medium, a fluid biomarker of neurodegeneration commonly used in clinical settings. Local microinjection of αS seeds resulted in spreading of αS inclusions to neuronally connected hippocampal subregions, and seeding and spreading could be inhibited by an αS seed-recognizing human antibody. We then applied parameters of the murine cultures to surgical resection-derived adult human long-term neocortical slice cultures from 22 to 61-year-old donors. Similarly, in these human slice cultures, proof-of-principle induction of αS lesions was achieved at 1week post-seeding in combination with viral A53T-αS expressions. Conclusion: The successful translation of these brain cultures from mouse to human with the first reported induction of human αS lesions in a true adult human brain environment underlines the potential of this model to study proteopathic lesions in intact mouse and now even aged human brain environments.

1 April 2025 in Journal of Neurophysiology
Verified
Journal Article
Open access
KSKerstin D. Schünemann
Kerstin D. Schünemann
RHRoxanne M. Hattingh
Roxanne M. Hattingh
MVMatthijs B. Verhoog
Matthijs B. Verhoog
DYDanqing Yang
Danqing Yang
ABAniella V. Bak
Aniella V. Bak
HKHenner Koch
Henner Koch
This study presents a dataset of nearly 4,000 morphologically reconstructed human dendritic spines across different ages, gender, and tissue conditions. The dataset was further used to evaluate a deep learning algorithm for three-dimensional spine reconstruction, offering a scalable method for semiautomated spine analysis across various tissues and microscopy setups. The findings enhance understanding of human neurology, indicating potential connections between spine morphology, brain function, and the mechanisms of neurological and psychiatric diseases.

30 September 2024 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Open access
ABAlexander Brenner
Alexander Brenner
FKFelix Knispel
Felix Knispel
FFFlorian P. Fischer
Florian P. Fischer
PRPeter Rossmanith
Peter Rossmanith
YWYvonne Weber
Yvonne Weber
EKEkaterina Kutafina
Ekaterina Kutafina
Despite recent performance advancements, deep learning models are not yet adopted in clinical practice on a wide scale. The intrinsic intransparency of such systems is commonly cited as one major reason for this reluctance. This has motivated methods that aim to provide explanations of model functioning. Known limitations of feature-based explanations have led to an increased interest in concept-based interpretability. Testing with Concept Activation Vectors (TCAV) employs human-understandable, abstract concepts to explain model behavior. The method has previously been applied to the medical domain in the context of electronic health records, retinal fundus images and magnetic resonance imaging. We explore the usage of TCAV for building interpretable models on physiological time series, using an example of abnormality detection in electroencephalography (EEG). For this purpose, we adopt the XceptionTime model, which is suitable for multi-channel physiological data of variable sizes. The model provides state-of-the-art performance on raw EEG data and is publically available. We propose and test several ideas regarding concept definition through metadata mining, using additional labeled EEG data and extracting interpretable signal characteristics in the form of frequencies. By including our own hospital data with analog labeling, we further evaluate the robustness of our approach. The tested concepts show a TCAV score distribution that is in line with the clinical expectations, i.e. concepts known to have strong links with EEG pathologies (such as epileptiform discharges) received higher scores than the neutral concepts (e.g. sex). The scores were consistent across the applied concept generation strategies. TCAV has the potential to improve interpretability of deep learning applied to multi-channel signals as well as to detect possible biases in the data. Still, further work on developing the strategies for concept definition and validation on clinical physiological time series is needed to better understand how to extract clinically relevant information from the concept sensitivity scores.